Microsize

Microsize was created from a growing demand for solubility and bioavailability enhancements utilizing Solubility Characterization technologies that accelerate Speed-to-Market & Optimization. Microsize is the largest, independent CDMO in the U.S. specializing in solubility enhancement and particle size reduction for the Pharma industry, from small-scale, pre-clinical development to full-scale cGMP commercial manufacturing. We are focused on the DS » DP interface. With over 30 years of experience, Microsize has developed deep subject matter expertise around micronization and the associated analytical, quality, and containment systems critical to delivering the results required by the pharmaceutical industry across the spectrum of APIs & excipients, including HPAPIs, regulated and controlled substances and other difficult to handle materials.